Literature DB >> 12928376

Dissociating the enhancing and inhibitory effects of pertussis toxin on autoimmune disease.

Shao Bo Su1, Phyllis B Silver, Peng Wang, Chi-Chao Chan, Rachel R Caspi.   

Abstract

Pertussis toxin (PT) has both enhancing and inhibitory effects on experimental autoimmune disease, depending on its time of administration relative to immunization. The inhibitory effect is due to blocking of G(i)-coupled receptors by the enzymatic A subunit. In this study, we attribute the enhancing effect of PT to the cell-binding B subunit (PT-B). C57BL/6 mice, a strain that requires PT to develop experimental uveitis, were immunized with a retinal Ag and were injected with whole PT, PT-B, or vehicle. Disease and associated immunological responses were evaluated. The results showed that PT-B, determined to be free of biologically significant contamination with whole PT or with endotoxin, was able to mimic all the effects of PT with respect to disease induction, enhancement of delayed-type hypersensitivity, enhancement of lymphocyte proliferation, induction of an innate IL-12 response, and promotion of an adaptive IFN-gamma response to the uveitogenic Ag. Our results suggest that PT-B is largely responsible for the disease-enhancing properties of PT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928376     DOI: 10.4049/jimmunol.171.5.2314

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Rodent models of experimental autoimmune uveitis.

Authors:  Rajeev K Agarwal; Phyllis B Silver; Rachel R Caspi
Journal:  Methods Mol Biol       Date:  2012

2.  Paradoxical effect of pertussis toxin on the delayed hypersensitivity response to autoantigens in mice.

Authors:  Rajwahrdhan Yadav; Sourojit Bhowmick; Philip Gorecki; James O'Rourke; Robert E Cone
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

3.  The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model.

Authors:  Jiazhu Fang; Dan Fang; Phyllis B Silver; Feng Wen; Bing Li; Xiangrong Ren; Qing Lin; Rachel R Caspi; Shao Bo Su
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-27       Impact factor: 4.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.